quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:15:29·24d
SECFiling
Aura Biosciences Inc. logo

SEC Form 10-K filed by Aura Biosciences Inc.

AURA· Aura Biosciences Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • AURA
    Aura Biosciences Inc.
    Health Care

Recent analyst ratings

  • Nov 26UpdateEvercore ISI$13.00
  • May 28UpdateH.C. Wainwright$22.00
  • Jul 25UpdateH.C. Wainwright$21.00
  • Jul 27UpdateScotiabank-
  • Apr 17UpdateBTIG Research$38.00
  • Jul 19UpdateJMP Securities$26.00

Related

  • SEC3d
    SEC Form DEFA14A filed by Aura Biosciences Inc.
  • SEC3d
    SEC Form DEF 14A filed by Aura Biosciences Inc.
  • INSIDER7d
    SEC Form 4 filed by Kilroy Conor
  • SEC24d
    SEC Form S-8 filed by Aura Biosciences Inc.
  • PR25d
    Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
  • SEC24d
    Aura Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
  • INSIDER51d
    Officer De Los Pinos Elisabet was granted 166,000 shares, increasing direct ownership by 41% to 575,815 units (SEC Form 4)
  • INSIDER51d
    Officer Gibney Anthony S was granted 71,245 shares, increasing direct ownership by 34% to 278,178 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022